Hypotension in transgenic mice overexpressing human bradykinin B2 receptor

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 488-493

  Wang, Dan Zhao ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hoe 140; human bradykinin B2 receptor; hypotension; transgenic mice; uterine contraction

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HYPOTENSION; KALLIKREIN KININ SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; TRANSGENIC MOUSE; UTERUS CONTRACTION;

EID: 85026134673     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.488     Document Type: Article

References (34)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
2. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
3. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992;56:131-190.
4. Olmsted F, Page IH. Hemodynamic effects of eledoisin, kallidin II and bradykinin in unanesthetized dogs. Am J Physiol. 1962;203: 951-954.
5. Elliot R, Nuzum FR. Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology. 1934;18:462-474.
6. Margolius HS, Geller RG, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet. 1971;2:1063-1065.
7. Carretero OA, Polomski C, Hampton A, Scicli AG. Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin Exp Pharmacol Physiol. 1976;3:55-59.
8. Ader JL, Tran-Van T, Praddaude FJ. Low urinary excretion of active and total kallikrein in young spontaneously hypertensive rats and effect of long-term angiotensin converting enzyme inhibition. J Hypertens. 1986;4:151-153.
9. Woodley-Miller C, Chao J, Chao L. Restriction fragment length polymorphism mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens. 1989;7:865-871.
10. Pravenec M, Ken V, Kunes J, Scicli G, Carrretero OA, Simonet LI. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension. 1991;17:242-246.
11. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 1994;23:236-243.
12. Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest. 1995;95:1710-1716.
13. Chao J, Chao L. Functional analysis of human tissue kallikrein in transgenic mouse models. Hypertension. 1996;27:491-494.
14. Song Q, Chao J, Chao L. High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model. Clin Exp Hypertens. In press.
15. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992;184:260-268.
16. 2 receptor. Genomics. 1994;23:362-369.
17. 2 receptor. Gene. 1994;149:283-288.
18. 2 receptor gene. Biochim Biophys Acta. 1994;1219:171-174.
19. 2 bradykinin receptor gene. J Biol Chem. 1994;269:26920-26925.
20. 2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun. 1995;211:226-233.
21. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem. 1995;270:13706-13710.
22. Madeddu P, Parpaglia PP, Glorioso N, Chao L, Chao J. Antisense inhibition of the kallikrein-kinin system in spontaneously hypertensive rats. Hypertension. In press.
23. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 1984;25:383-390.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
25. Bieberich CJ, Utsel MF, Awgulewitsch A, Ruddle FH. Evidence for positive and negative regulation of the Hox-3.1 gene. Proc Natl Acad Sci U S A. 1990;87:8462-8466.
26. Manning DC, Vavrek R, Stewart JM, Snyder SH. Two bradykinin binding sites with picomolar affinities. J Pharmacol Exp Ther. 1986; 237:504-512.
27. 2-kinin binding sites. Am J Physiol. 1989;257:F353-F358.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
29. McPherson GA. Computer-assisted analysis of complex concentration-response data. J Pharmacol Methods. 1985;13:125-134.
30. 2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991;88:7724-7728.
31. Saameli K, Eskes TKAB. Bradykinin and cardiovascular system: estimation of half-life. Am J Physiol. 1962;203:261-265.
32. 2 receptor act as inverse agonists in rat myometrial cells. J Biol Chem. 1994;269: 25970-25973.
33. 2-adrenoceptor. Nature. 1995;374:272-276.
34. 2-adrenergic receptor. Science. 1994;264:582-586.